spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Inhaled Insulin 

 HSMN NewsFeed - 27 Jun 2017
Dance Biopharm Appoints Steve Thornton to Board of Directors
Biopharmaceuticals Drug Delivery Endocrinology Personnel
 HSMN NewsFeed - 18 Apr 2017
Eiger Announces Industry Veteran Lisa Porter, M.D. to Lead Development of Exendin 9-39 for the Treatment of Post-Bariatric Hypoglycemia
Biopharmaceuticals Gastroenterology Surgery Personnel
 HSMN NewsFeed - 18 Feb 2015
Dance Biopharm Completes $9.5 Million Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Aug 2014
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin
Biopharmaceuticals Endocrinology Drug Delivery Licensing
 HSMN NewsFeed - 28 Dec 2010
MannKind Updates Status of New Drug Application for AFREZZA(R)
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 2 Jun 2009
Bionovo Appoints Dr. Klaus Kohl as Chief Technical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Mar 2009
MannKind Submits NDA for AFRESA for Treatment of Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 31 Dec 2008
Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 21 Oct 2008
Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 23 Sep 2008
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2008
Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated with AERx(R) Insulin Diabetes Management System (iDMS)
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 10 Apr 2008
MannKind Addresses Pfizer's Announcement Regarding Exubera
Biopharmaceuticals Drug Delivery Endocrinology Oncology
 HSMN NewsFeed - 9 Apr 2008
Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
Biopharmaceuticals Endocrinology Oncology
 HSMN NewsFeed - 9 Apr 2008
Pfizer Statement on Exubera Labeling Update in the United States
Biopharmaceuticals Endocrinology Oncology
 HSMN NewsFeed - 19 Mar 2008
Alkermes Announces Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2008
Alkermes Receives Notice from Eli Lilly Terminating Inhaled Insulin Program
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 7 Mar 2008
Lilly Announces Termination of AIR Insulin Program
Biopharmaceuticals Endocrinology Drug Delivery
 HSMN NewsFeed - 7 Mar 2008
Alkermes Provides Update on Inhaled Insulin Program
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 12 Feb 2008
Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2007
Pfizer and Nektar Reach Agreement on Exubera(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 1 Nov 2007
Generex Biotechnology Receives Regulatory Approval to Sell Generex Oral-lyn in India
Biopharmaceuticals Drug Delivery Endocrinology Regulatory
 HSMN NewsFeed - 18 Oct 2007
Nektar Therapeutics Issues Statement on Exubera
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 20 Apr 2007
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 9 Apr 2007
Innovative Pulmonary and PEGylation-Based Therapeutic Product Development Drives Business Strategy of Nektar Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2007
Alkermes and Lilly Expand AIR(R) Inhaled Insulin Collaboration
Biopharmaceuticals Endocrinology Drug Delivery Licensing
 HSMN NewsFeed - 14 Dec 2006
Novo Nordisk to Pursue Lawsuit Despite Preliminary Injunction Denial
Biopharmaceuticals Litigation
 HSMN NewsFeed - 14 Dec 2006
Court Denies Novo Nordisk's Motion for Preliminary Injunction Against Exubera
Biopharmaceuticals Litigation
 HSMN NewsFeed - 6 Nov 2006
Abbott to Expand Presence in Lipid Management Market With Acquisition of Kos Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Oct 2006
Amylin Pharmaceuticals Appoints Joe Young Sr. Vice President, Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2006
Type 2 Diabetes Patients on Technosphere Insulin Exhibited No Adverse Effect on Pulmonary Function with Significant HbA1c Reductions, and Showed Significant Weight Reduction Compared to Injected Insulin Analog
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 14 Sep 2006
MannKind Corporation Completes Patient Enrollment for the Major Phase 3 Safety Study of Technosphere(R) Insulin in Patients With Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 14 Sep 2006
Exubera Effective in Diabetes Patients who Have Respiratory Infections or are Exposed to Passive Cigarette Smoke, New Analyses Show
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 12 Sep 2006
John Timberlake Joins Valeritas from sanofi-aventis as Executive Vice President and General Manager of Metabolics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Aug 2006
Zogenix, Inc. Names Founding Management Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 2 Aug 2006
Novo Nordisk Sues Pfizer for Patent Infringement
Biopharmaceuticals Endocrinology Drug Delivery Litigation
 HSMN NewsFeed - 5 Jul 2006
Aradigm and Novo Nordisk Execute Further Restructuring of Partnership
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 5 Jun 2006
Lilly and Alkermes Complete Patient Enrollment for Phase 3 Safety Study for Inhaled Insulin for the Treatment of Diabetes
Biopharmaceuticals Endocrinology Drug Delivery
 HSMN NewsFeed - 28 Apr 2006
Aradigm Announces Update by Novo Nordisk on AERx Inhaled Insulin Phase 3 Clinical Program
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 6 Mar 2006
MannKind Initiates Two U.S. Pivotal Phase 3 Studies of Inhaled Technosphere(R) Insulin
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 1 Mar 2006
Pfizer Completes Acquisition of Worldwide Rights to Exubera From sanofi-aventis
Biopharmaceuticals Endocrinology Acquisitions
 HSMN NewsFeed - 27 Jan 2006
Pfizer Receives FDA Approval for Exubera, the First Inhalable Form of Insulin for Controlling Type 1 and Type 2 Diabetes in Adults
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 27 Jan 2006
Pfizer Statement on Status of Exubera Filing in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 26 Jan 2006
European Commission Approves Exubera(R) (Inhaled Human Insulin) for Treatment of Type 1 and Type 2 Diabetes
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Jan 2006
MannKind Corporation Announces Positive Results From a Phase 2b Dose-Ranging Study of Technosphere(R) Insulin in Patients With Type 2 Diabetes
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 13 Jan 2006
Pfizer to Purchase sanofi-aventis Rights to Exubera(R) in Application of Change of Control Clauses
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 Jan 2006
Pfizer to Acquire the sanofi-aventis Worldwide Rights to Exubera(R) (Inhaled Human Insulin)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 9 Jan 2006
Alkermes and Lilly Announce Agreement for the Development and Commercialization of Inhaled Parathyroid Hormone for the Treatment of Osteoporosis
Biopharmaceuticals Drug Delivery
Return to NewsFeed  

 Additional items found! 29

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 29 additional stories matching:
Inhaled Insulin
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.